These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 21879887)

  • 1. Obtained mydriasis in long-term type 2 diabetic patients.
    Lei HL; Yang KJ; Sun CC; Chen CH; Huang BY; Ng SC; Yeung L
    J Ocul Pharmacol Ther; 2011 Dec; 27(6):599-602. PubMed ID: 21879887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison between obtained mydriasis in type 2 diabetics and non-diabetic patients.
    Coblentz J; Motta MM; Fernandes BF; Burnier MN; Vianna RN
    Curr Eye Res; 2009 Nov; 34(11):925-7. PubMed ID: 19958108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in the shape of the anterior and posterior corneal surfaces caused by mydriasis and miosis: detailed analysis.
    Saitoh K; Yoshida K; Hamatsu Y; Tazawa Y
    J Cataract Refract Surg; 2004 May; 30(5):1024-30. PubMed ID: 15130639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single dose of 1% tropicamide and 10% phenylephrine for pupil dilation.
    Ratanapakorn T; Yospaiboon Y; Chaisrisawadsuk N
    J Med Assoc Thai; 2006 Nov; 89(11):1934-9. PubMed ID: 17205877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of mydriatic eye drops on wavefront sensing with the Zywave aberrometer.
    Taneri S; Oehler S; Azar DT
    J Refract Surg; 2011 Sep; 27(9):678-85. PubMed ID: 21446641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of nonmydriatic spectral-domain optical coherence tomography for diagnosing diabetic macular edema.
    Medina FJ; Callén CI; Rebolleda G; Muñoz-Negrete FJ; Callén MJ; del Valle FG
    Am J Ophthalmol; 2012 Mar; 153(3):536-543.e1. PubMed ID: 21996307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2.5% and 10% phenylephrine for mydriasis in diabetic patients with darkly pigmented irides.
    Suwan-Apichon O; Ratanapakorn T; Panjaphongse R; Sinawat S; Sanguansak T; Yospaiboon Y
    J Med Assoc Thai; 2010 Apr; 93(4):467-73. PubMed ID: 20462091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effectiveness of mydriasis by two instillation methods of combined 0.75% tropicamide and 2.5% phenylephrine eye drop in preterm infants.
    Phamonvaechavan P; Chutasmit K; Damrongrak P; Koukiatkul S; Wongkiatkajorn T; Ngerncham S
    J Med Assoc Thai; 2012 Apr; 95 Suppl 4():S1-7. PubMed ID: 22696845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A combination solution for routine pupillary dilation.
    Krumholz DM; Portello JK; Rosenfield M; Rosenbaum JD
    Optometry; 2006 Jul; 77(7):350-3. PubMed ID: 16814239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pupil size before and after phacoemulsification in nondiabetic and diabetic patients.
    Hayashi K; Hayashi H
    J Cataract Refract Surg; 2004 Dec; 30(12):2543-50. PubMed ID: 15617922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ocular and cardiovascular autonomic function in diabetic patients with varying severity of retinopathy.
    Datta S; Biswas NR; Saxena R; Deepak KK; Menon V; Garg SP; Tandon R
    Indian J Physiol Pharmacol; 2005 Apr; 49(2):171-8. PubMed ID: 16170985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgically induced miosis during phacoemulsification in patients with diabetes mellitus.
    Mirza SA; Alexandridou A; Marshall T; Stavrou P
    Eye (Lond); 2003 Mar; 17(2):194-9. PubMed ID: 12640406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mydriatic and cardiovascular effects of phenylephrine 2.5% versus phenylephrine 10%, both associated with tropicamide 1%.
    Motta MM; Coblentz J; Fernandes BF; Burnier MN
    Ophthalmic Res; 2009; 42(2):87-9. PubMed ID: 19478547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pupil dilation with intracameral lidocaine during phacoemulsification.
    Nikeghbali A; Falavarjani KG; Kheirkhah A; Bakhtiari P; Kashkouli MB
    J Cataract Refract Surg; 2007 Jan; 33(1):101-3. PubMed ID: 17189802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pupil dilatation after single and triple doses of mydriatic agent in preterm infants.
    Punyawattanaporn A; Tengtrisorn S; Sangsupawanich P
    J Med Assoc Thai; 2009 Nov; 92(11):1458-62. PubMed ID: 19938737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetic retinopathy. Screening and prevention of blindness. A doctoral thesis.
    Kristinsson JK
    Acta Ophthalmol Scand Suppl; 1997; (223):1-76. PubMed ID: 9559048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative pupil dilation using phenylephrine alone or in combination with tropicamide.
    Eyeson-Annan ML; Hirst LW; Battistutta D; Green A
    Ophthalmology; 1998 Apr; 105(4):726-32. PubMed ID: 9544648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted mydriasis strategies for diabetic retinopathy screening clinics.
    Dervan EW; O'Brien PD; Hobbs H; Acheson R; Flitcroft DI
    Eye (Lond); 2010 Jul; 24(7):1207-12. PubMed ID: 20139914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of mydriatics on intraocular pressure and pupil size in the normal feline eye.
    Stadtbäumer K; Frommlet F; Nell B
    Vet Ophthalmol; 2006; 9(4):233-7. PubMed ID: 16771758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of phenylephrine and pilocarpine on pupil size and aqueous flare intensity in patients with diabetes mellitus.
    Zaczek A; Zetterström C
    Acta Ophthalmol Scand; 1998 Aug; 76(4):413-6. PubMed ID: 9716326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.